retatrutide clinical trial weight loss A new weight-loss drug called is generating excitement after participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Trial Data Dosing Schedule :
Description
Danish pharmaceutical titan Novo Nordisk has applied to Chinas drug regulator to widen the range of use of its diabetes medicine Ozempic

A summary of clinically-significant GLP-1RAs described in this text and their clinical uses are listed in Table 1

CVS Caremark negotiated a deal with Novo Nordisk (Wegovy's manufacturer) that made Wegovy the preferred GLP-1 medication starting July 2025

The clinical risk adverse events tied to Novos name wasnt worth the extra volume
Semaglutide is the first FDA-approved weight loss medication since 2014

Maina JG, Balkhiyarova Z, Nouwen A, Pupko I, Ulrich A, Boissel M, et al